| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.52 | 0.004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.49 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.42 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.38 | 0.06 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.35 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |